Skip to main content
JDA Capital Services Limited
Notices
IPO of Maxwell Engineering Solutions Limited (NSE Emerge) opens on 30 October 2026 and closes on 3 November 2026. Price band ₹150–₹158 per share. JDA Capital Services Limited is the Book Running Lead Manager.Dear Investor, please note that the account closing facility is now available online and can be accessed with your login credentials on https://rekyc.beelinebroking.com/. For the detailed procedure, see the Online Account Closure Procedure Manual (PDF).Stock brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.Update your mobile number & email ID with your stock broker / depository participant and receive OTP directly from the depository on your email ID and/or mobile number to create a pledge.Pay 20% upfront margin of the transaction value to trade in the cash market segment.Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.Investors may please refer to the Investor Charter as per SEBI circular Ref No. SEBI/HO/IMD/IMD-II CIS/P/CIR/2 dated December 13, 2021.View all Notices

Home/Recent Deals/Chandra Bhagat Pharma Limited

Deal details

Chandra Bhagat Pharma Limited

Lead Manager to the Public Issue (SME IPO) of ₹10.20 Cr, listed on BSE SME in 2020.

Completed

Deal at a Glance

A snapshot of the Chandra Bhagat Pharma Limited SME IPO.

RoleLead Manager
TypePublic Issue (SME IPO)
SectorPharmaceuticals
Issue size₹10.20 Cr
ExchangeBSE SME
Year2020

IPO Timetable

Key dates of the Chandra Bhagat Pharma Limited public issue.

  1. 1IPO Open31 Jan 2020
  2. 2IPO Close06 Feb 2020
  3. 3Allotment11 Feb 2020
  4. 4Refund13 Feb 2020
  5. 5Credit13 Feb 2020
  6. 6Listing14 Feb 2020

About Chandra Bhagat Pharma Limited

Updated on 23 Oct 2026

Contract manufacturing and job work of pharmaceutical products; supplies injectables, tablets and capsules under the CBC brand (incorporated 2003).

The public issue opened on 31 Jan 2020 and closed on 06 Feb 2020. The company raised ₹10.20 Cr through a Public Issue (SME IPO) of equity shares at ₹51 per share (face value ₹10, lot size 2,000 shares). The shares were listed on BSE SME on 14 Feb 2020 at an opening price of ₹51.70.

JDA Capital Services Limited acted as Lead Manager to the issue. Registrar: MUFG Intime India Private Limited (formerly Link Intime). Market maker: Beeline Broking Limited.

Currently listed on BSE SME.

Transaction Overview

Issue terms of the Chandra Bhagat Pharma Limited SME IPO, with JDA Capital as Lead Manager.

InstrumentEquity Shares (Public Issue, SME IPO)
Issue size₹10.20 Cr
ExchangeBSE SME
Role of JDA CapitalLead Manager
Face value₹10 per share
Issue price₹51 per share
Lot size2,000 shares
Issue typeFresh issue
Listing price₹51.70
Subscription1.57x

Registrar, Lead Manager & Contact Details

Registrar, lead manager and company contact details for the Chandra Bhagat Pharma Limited issue.

IPO Registrar

MUFG Intime India Private Limited (formerly Link Intime)

IPO Lead Manager(s)

  1. JDA Capital Services Limited

Market Maker

  • Beeline Broking Limited

Lead Manager Reports

Contact Details

Chandra Bhagat Pharma Limited. Address

323-F Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai 400019, Maharashtra

How JDA Capital Supported the Transaction

How JDA Capital supported the company from preparation to listing.

  1. Understand

    We study the company's business model, financials and growth plans to define the fund-raising objective.

  2. Evaluate

    We assess readiness, valuation and the right listing platform for the company.

  3. Structure

    We design the issue structure, size and price band and prepare the offer documents with legal and auditor teams.

  4. Execute

    We coordinate regulators, exchange, registrar, banker and market maker through filing, marketing, bidding and allotment.

  5. Create Value

    We support listing day and post-listing compliance so the company can use the market to grow.

Have a deal like this in mind?

Speak to a senior member of our team about your own plans.

Similar mandate?

Planning a Similar Transaction?

Tell us about your requirement and we will discuss how a transaction like this could work for you.

What happens next
  1. 01

    Share your requirement

    Tell us about the business and what you want to achieve.

  2. 02

    We review and respond

    A senior member of the team reviews your enquiry and gets back to you.

  3. 03

    Plan the way forward

    We outline the options and the right path for the transaction.

Advisory engagements are subject to mandate, eligibility and applicable regulatory requirements.

Tell us about your requirement

Fields marked with * are required.